XML 29 R19.htm IDEA: XBRL DOCUMENT v3.10.0.1
Interim Financial Statements (Tables)
 9 Months Ended
Sep. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of New Accounting Pronouncements and Changes in Accounting Principles
The following tables summarize the impacts of adopting ASC 606 on the Company's condensed consolidated financial statements as of and for the three and nine months ended September 30, 2018 compared with the guidance that was in effect before the change.
 
 
September 30, 2018
Balance Sheet Data
 
As Reported
 
Adjustments
 
Balance Without Adoption of ASC 606
Inventories
 
$
1,039,679

 
$
17,518

 
$
1,057,197

Deferred tax assets
 
$
562,818

 
$
(15,027
)
 
$
547,791

Total assets
 
$
10,805,613

 
$
2,491

 
$
10,808,104

Accrued expenses and other current liabilities
 
$
781,924

 
$
(1,175
)
 
$
780,749

Deferred revenue from Sanofi (current)
 
$
246,812

 
$
(60,406
)
 
$
186,406

Deferred revenue - other (current)
 
$
216,133

 
$
(78,611
)
 
$
137,522

Total current liabilities
 
$
1,417,230

 
$
(140,192
)
 
$
1,277,038

Deferred revenue from Sanofi (noncurrent)
 
$
421,196

 
$
(28,078
)
 
$
393,118

Deferred revenue - other (noncurrent)
 
$
197,651

 
$
32,952

 
$
230,603

Total liabilities
 
$
2,937,313

 
$
(135,318
)
 
$
2,801,995

Retained earnings
 
$
4,433,904

 
$
137,809

 
$
4,571,713

Total stockholders' equity
 
$
7,868,300

 
$
137,809

 
$
8,006,109

Total liabilities and stockholders' equity
 
$
10,805,613

 
$
2,491

 
$
10,808,104


 
 
Three Months Ended
September 30, 2018
 
Nine Months Ended
September 30, 2018
Consolidated Statement of Operations Data
 
As Reported
 
Adjustments
 
Balance Without Adoption of ASC 606
 
As Reported
 
Adjustments
 
Balance Without Adoption of ASC 606
Sanofi collaboration revenue
 
$
256,265

 
$
12,172

 
$
268,437

 
$
683,508

 
$
(5,159
)
 
$
678,349

Other revenue
 
$
117,370

 
$
24,574

 
$
141,944

 
$
314,552

 
$
(22,615
)
 
$
291,937

Total revenues
 
$
1,663,496

 
$
36,746

 
$
1,700,242

 
$
4,783,003

 
$
(27,774
)
 
$
4,755,229

Cost of collaboration and contract manufacturing
 
$
79,552

 
$
(17,518
)
 
$
62,034

 
$
180,918

 
$
(17,518
)
 
$
163,400

Income from operations
 
$
626,923

 
$
54,264

 
$
681,187

 
$
1,816,342

 
$
(10,256
)
 
$
1,806,086

Income before income taxes
 
$
635,861

 
$
54,264

 
$
690,125

 
$
1,877,333

 
$
(10,256
)
 
$
1,867,077

Income tax expense
 
$
(41,206
)
 
$
(2,663
)
 
$
(43,869
)
 
$
(253,286
)
 
$
4,630

 
$
(248,656
)
Net income
 
$
594,655

 
$
51,601

 
$
646,256

 
$
1,624,047

 
$
(5,626
)
 
$
1,618,421